Cell and Gene Therapy Answers: Assessing the Critical Quality Attributes, Challenges and Importance of CMC in Development of Cell & Gene Therapy

We recently spoke with Labcorp Drug Development team member Paul Byrne, Principal Scientist, Cell & Gene Therapy, Biopharmaceutical CMC Solutions. He shared an introduction to CMC, key analytical methods used in assessing the Critical Quality Attributes, challenges in developing these assays and his thoughts on the road ahead over the next 5-10 years.